Original researchType 2 diabetes and cardiovascular disease in South Asians
Introduction
South Asians have origins on the Indian sub-continent (India, Pakistan, Bangladesh, Sri Lanka and Nepal) and collectively they form 20% of the world population. Since the Second World War there has been a progressive migration of people from these countries to many countries in Europe and North America. In UK they are the largest ethnic minority group comprising over 4% of the total UK population [1]. Cardiovascular diseases (CVD) (which include coronary heart disease (CHD) and stroke) are of pandemic status with significant mortality and morbidity and consequent economic impact [2], [3]. However there is significant ethnic variation in its prevalence with South Asians not only on the sub-continent, but also in diaspora harbouring the highest risk of developing these diseases, with a projection illustrating that in 2020 South Asians will contribute 40% of the global CVD burden [4], [5], [6], [7]. Furthermore CVD and type 2 diabetes (T2DM) develop at an earlier age in South Asians and associated complications are seen more commonly compared to white Europeans [6], [7], [8], [9], [10], [11], [12], [13]. The reason for this heightened CVD risk in South Asians is not entirely clear but is thought to be mainly related to high prevalence of insulin resistance and related atherogenic risk factors in this population [6], [14]. It is also likely that factors associated with urban lifestyle/migration such as high calorie diet and lack of physical activity further enhances the underlying insulin resistance and consequent cardiovascular risk. The problem is further made worse by the paucity of evidence based knowledge and guidelines on primary and secondary prevention of CVD specific to this ethnic community [15]. Moreover, factors such as health beliefs, language difficulties, educational level, socioeconomic status and inequalities in access to health care have a further adverse impact on the effective management and outcome of CVD in this population [1]. Not surprisingly, there seems to be a lack of relative decline in CHD and stroke rates in this population compared to Europeans [9], suggesting the inequalities gap is not being as successfully addressed as desired, despite an overall fall in absolute rates in areas such as CHD.
The aim of this article is to review the literature and update the readers on epidemiology, risk factors and pathogenesis of T2DM and CVD in migrant South Asian populations. There have been extensive review articles on CHD and T2DM in South Asian community [16], [17], [18], [19], [20]. However with the recent launch of the NHS Health Checks Programme in England [21], the publication of this updated review is timely and pertinent.
Section snippets
Epidemiology
Currently 246 million people worldwide are affected by diabetes and the number is expected to rise to 380 million by 2025. A substantial 80% increase will be seen in middle to low income countries and the highest rise will be seen in Indian sub-continent [3], [22]. The prevalence of T2DM in the South Asian population living in the UK is around 20% which is nearly fivefold higher than the indigenous White population. Previous studies have also shown that in up to 40% of cases the disease remains
Chronic heart failure
Chronic heart failure (CHF) is a major health problem with a high prevalence and is associated with high mortality and morbidity [103]. People with T2DM are at a significantly high risk of developing heart failure and associated mortality [104]. Possible mechanisms that may explain the underling adverse association of T2DM with CHF include the increased frequency of hypertension and premature CHD and the presence of a distinct diabetic cardiomyopathy possibly resulting from the metabolic
Cerebrovascular disease
Gunarathne et al. in a recent review article have given a detailed account of current evidence related to ischaemic strokes in the South Asian populations [113]. Like CHD, South Asians experience greater burden of stroke and suffer from premature and at least 40% higher stroke related mortality compared to white Europeans [113], [114]. Available information shows that, over the past few decades there has been a tremendous rise in incidence and prevalence of stroke affecting South Asian
Peripheral arterial disease (PAD)
PAD is an important vascular disease with considerable mortality, morbidity and is also associated with increased rates of hospitalisation and reduced quality of life. It is frequently seen in association with other vascular diseases such as CHD, stroke and T2DM. While there is ample information available on PAD in white European populations, much less is known about this disease in South Asian and other ethnic groups. Bennett et al. have recently reviewed the evidence on PAD in different
Raising awareness
Increasing awareness amongst patients as well as healthcare professionals about the heightened risk of CVD and T2DM is of paramount importance. Wider efforts need to be taken at national level with input from healthcare professionals, non-government organisations, diabetes organisations, government authorities and community leaders to tackle this challenge. In UK, the South Asian Health Foundation (SAHF) in collaboration with Diabetes UK and Department of Health is working in this direction.
Conclusions
South Asian populations worldwide have a high prevalence of CVD and T2DM, occurring at an earlier age and being associated with premature and high mortality. Conventional as well as novel risk factors related to central obesity and insulin resistance and the risk factors associated with urban lifestyle are all likely to be contributing in majority of the cases. While more research is awaited in this area, it is reasonable to adopt the current guidelines on primary and secondary prevention of
Conflict of interest statement
Kamlesh Khunti (KK) and Kiran Patel are members of the South Asian Health Foundation. Kamlesh Khunti co-lead the review ‘Diabetes UK and South Asian Health Foundation recommendations on diabetes research priorities for British South Asians’.
References (151)
- et al.
Heart disease epidemic in Pakistan: women and men at equal risk
Am. Heart J.
(2005) - et al.
Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians
Lancet
(1991) - et al.
Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)
Lancet
(2000) - et al.
The Y–Y paradox
Lancet
(2004) - et al.
Relationship of glucose and insulin levels to the risk of myocardial infarction: a case–control study
J. Am. Coll. Cardiol.
(1999) Early life origins of insulin resistance and type 2 diabetes in India and other Asian countries
J. Nutr.
(2004)- et al.
Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment
Lancet
(2003) - et al.
Apolipoprotein A1 and B
Clin. Lab. Med.
(2006) - et al.
Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case–control study
Lancet
(2008) - et al.
Lipid profile, plasma apolipoproteins, and risk of a first myocardial infarction among Asians: an analysis from the INTERHEART study
J. Am. Coll. Cardiol.
(2009)
Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case–control study
Lancet
Enhanced diabetes care to patients of south Asian ethnic origin (the United Kingdom Asian Diabetes Study): a cluster randomised controlled trial
Lancet
Lessons from the study of immigrant mortality
Lancet
Relationship of hyperinsulinemia to dietary intake in south Asian and European men
Am. J. Clin. Nutr.
CVD risk factors and ethnicity – a homogeneous relationship?
Atheroscler. Suppl.
Ethnic differences in cardiovascular risk factors in healthy Caucasian and South Asian individuals with the metabolic syndrome
J. Thromb. Haemost.
Cultural aspects
Cardiovascular disease in non-western countries
N. Engl. J. Med.
The Southall Diabetes Survey: prevalence of known diabetes in Asians and Europeans
Br. Med. J. (Clin. Res. Ed.)
Mortality and morbidity from diabetes in South Asians and Europeans: 11-year follow-up of the Southall Diabetes Survey, London, UK
Diabet. Med.
Risk factors for early myocardial infarction in South Asians compared with individuals in other countries
JAMA
Do known risk factors explain the higher coronary heart disease mortality in South Asian compared with European men? Prospective follow-up of the Southall and Brent studies, UK
Diabetologia
Trends for coronary heart disease and stroke mortality among migrants in England and Wales, 1979–2003: slow declines notable for some groups
Heart
Diabetes prevalence in England, 2001 – estimates from an epidemiological model
Diabet. Med.
The burden of cardiovascular disease in the Indian subcontinent
Indian J. Med. Res.
It's time to reappraise recruitment of South Asians to clinical trials
BMJ
Type 2 diabetes and cardiovascular risk in the UK south Asian community
Diabetologia
Cardiovascular risk in South Asians
Postgrad. Med. J.
Diabetes and cardiac disease in South Asians
Br. J. Diabetes Vasc. Dis.
Prevention, Treatment and Rehabilitation of Cardiovascular Disease in South Asians
Putting Prevention First – NHS Health Check: Vascular Risk Assessment and Management Best Practice Guidance
Diabetes in Asia: epidemiology, risk factors, and pathophysiology
JAMA
Prevalence of diabetes in a predominantly Asian community: preliminary findings of the Coventry diabetes study
BMJ
The potential impact of using glycated haemoglobin as the preferred diagnostic tool for detecting type 2 diabetes mellitus
Diabet. Med.
Epidemiology
Health care needs assessments: Black and minority ethnic groups
Ethnicity and variations in the nation's health
Health Trends
Mortality from all causes and circulatory disease by country of birth in England and Wales 2001–2003
J. Public Health
Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study
BMJ
Risk factors, hospital management and outcomes after acute myocardial infarction in South Asian Canadians and matched control subjects
CMAJ
Comparison of case fatality in south Asian and white patients after acute myocardial infarction: observational study
BMJ
Baseline characteristics and risk of progression from prediabetes to type 2 diabetes in a multiethnic, population based screening
Diabet. Med.
Transient and persistent impaired glucose tolerance and progression to diabetes in South Asians and Europeans: new, large studies are a priority
Diabet. Med.
Impact of metabolic indices on central artery stiffness: independent association of insulin resistance and glucose with aortic pulse wave velocity
Diabetologia
Coronary risk in South Asians: role of ethnicity and blood sugar
Eur. J. Cardiovasc. Prev. Rehabil.
The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart
Eur. Heart. J.
Cited by (146)
In silico investigation on alkaloids of Rauwolfia serpentina as potential inhibitors of 3-hydroxy-3-methyl-glutaryl-CoA reductase
2021, Saudi Journal of Biological SciencesDesign and synthesis of new flavonols as dual ɑ-amylase and ɑ-glucosidase inhibitors: Structure-activity relationship, drug-likeness, in vitro and in silico studies
2020, Journal of Molecular StructureCitation Excerpt :It is estimated that in South Asian countries (India, Pakistan, Bangladesh, Sri Lanka, China and Nepal) 300 million people will have the disease by the year 2025 and that it will be able to reach 366 million in the year 2030 [7,8]. Analysis of the latest statistical data reveals that T2DM has become a serious issue in developed countries like the USA, Japan and China particularly being 45-64 years old and this issue is comparatively less harmful in lower middle income countries like Brazil, Pakistan, Bangladesh Russia and Indonesia [9]. An enlargement of weight during the childhood stage has resulted in T2DM becoming more common in teenagers and children, which is a very serious issue and a new public health problem in the future [10].